Your NEJM Group Today: End-of-Life Decisions in Netherlands / Oxytocin & Autism / California EM Opportunities — Physician’s First Watch
Your NEJM Group Today: End-of-Life Decisions in Netherlands / Oxytocin & Autism / California EM Opportunities
By the Editors
Check out our latest selections from NEJM Group:
NEJM Clinical Practice Center: Correspondence: Data from physicians in the Netherlands show that the percentage of patients in whom an end-of-life decision preceded death increased from 39% in 1990 to 58% in 2015. During this time, the euthanasia rate increased from 1.7% to 4.5%. Continuous deep sedation was provided in 18% of all deaths in 2015.
NEJM Journal Watch Psychiatry : Among children with autism spectrum disorder, a nasal oxytocin spray improved social capacity, with the strongest effects in children with the lowest plasma oxytocin levels at baseline.
NEJM CareerCenter: Loma Linda University Faculty Medical Group in southern California is seeking full-time emergency medicine physicians to join its growing EM department.